Tyra Biosciences’ $172.8 Million Initial Public Offering

Latham & Watkins represented Tyra Biosciences in the offering while Sidley advised the underwriters.Tyra Biosciences, Inc. has announced the pricing of its upsized initial public offering of 10,800,000…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here